Wellington Management Group LLP Vertex Pharmaceuticals Inc Transaction History
Wellington Management Group LLP
- $529 Billion
- Q2 2025
A detailed history of Wellington Management Group LLP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 4,813,386 shares of VRTX stock, worth $1.86 Billion. This represents 0.41% of its overall portfolio holdings.
Number of Shares
4,813,386
Previous 5,454,748
11.76%
Holding current value
$1.86 Billion
Previous $2.64 Billion
18.97%
% of portfolio
0.41%
Previous 0.53%
Shares
23 transactions
Others Institutions Holding VRTX
# of Institutions
1,810Shares Held
239MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$11.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.28 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.25 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.24 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.56 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $99.4B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...